Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study
Open Access
- 6 October 2009
- journal article
- case report
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 2 (1) , 42
Abstract
The occurrence of chronic myeloid leukemia in pregnancy is rare and its management poses a clinical challenge for physicians treating these patients. We report a 30-year-old woman with chronic myeloid leukemia who became pregnant twice successfully. Philadelphia-positive CML in its chronic phase was diagnosed at 16 weeks of her first gestation. At that time, she received no treatment throughout her pregnancy. At 38 weeks of gestation, a normal infant was delivered by cesarean section. At six weeks postpartum, the patient underwent imatinib mesylate therapy but she could not tolerate the treatment. The treatment was then changed to nilotinib at 400 mg orally b.i.d. Two years later, she became pregnant again while she was on nilotinib 200 mg b.i.d. The unplanned pregnancy was identified during her 7.4 weeks of gestation. Because the patient elected to continue her pregnancy, nilotinib was stopped immediately, and no further treatment was given until delivery. Neither obstetrical complications nor structural malformations in neonates in both pregnancies were observed. Both babies' growth and development have been normal. Although this experience is limited to a single patient, the success of this patient demonstrates that the management of chronic myeloid leukemia in pregnant women may be individualized based on the relative risks and benefits of the patient and fetus.Keywords
This publication has 18 references indexed in Scilit:
- The effects of imatinib on pregnancy outcomeBlood, 2008
- Pregnancy on imatinib: fatal outcome with meningoceleAnnals of Oncology, 2005
- Pregnancy outcome of two patients treated with imatinibAnnals of Oncology, 2005
- In vitro Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain MutantsCancer Research, 2005
- Imatinib in pregnancyEuropean Journal of Haematology, 2005
- Imatinib treatment: Specific issues related to safety, fertility, and pregnancySeminars in Hematology, 2003
- Hydroxyurea treatment for chronic myeloid leukemia during pregnancyActa Obstetricia et Gynecologica Scandinavica, 2000
- Interferon‐α therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemiaBritish Journal of Haematology, 1992
- Successful management of Ph chromosome chronic myelogenous leukemia with leukapheresis during pregnancyAmerican Journal of Hematology, 1991
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973